Johnson Pharmacare Ltd
Johnson Pharmacare Ltd (JOHNPHARMA) last reported results for the quarter ended Jun 2026, with sales of ₹0 crore and net profit of ₹-1.1 crore. The stock last traded at ₹0.46, a market capitalisation of ₹25.3 crore. Over the past 52 weeks the stock has ranged between ₹0.41 and ₹0.76. Figures are as of 6 Oct 2026 and are not real time.
Johnson Pharmacare Ltd share price and key metrics
- Current price
- ₹0.46
- Market cap
- ₹25.3 cr
- Book value
- ₹0.01
- ROE
- -146%
- ROCE
- -105%
- Dividend yield
- 0.00%
- 52w high / low
- 0.76/0.41
Metrics as of 6 Oct 2026. Not real time.
Track Johnson Pharmacare Ltd
Cruxal reads every Johnson Pharmacare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Johnson Pharmacare Ltd growth and returns
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- %
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -10019%
- 10 Years
- 1%
- 5 Years
- 3%
- 3 Years
- -8%
- 1 Year
- -40%
- 10 Years
- -8%
- 5 Years
- -16%
- 3 Years
- -30%
- Last Year
- -146%
Johnson Pharmacare Ltd quarterly results
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0 | 0.03 | 0.01 | 0.05 | 0 | 0.02 | 42.7 | 0.04 |
| Operating profit | 0 | -0.03 | -0.01 | -0.05 | 0 | -0.02 | -42.7 | -0.04 |
| OPM % | — | — | — | — | — | — | — | — |
| Other income | 0 | 0 | -0.5 | 0 | 0 | 0 | -12.69 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.22 | 1.06 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | -0.03 | -0.51 | -0.05 | 0 | -0.06 | -55.61 | -1.1 |
| Tax % | — | 0.00% | 0.00% | 0.00% | — | 0.00% | 0.00% | 0.00% |
| Net profit | 0 | -0.03 | -0.51 | -0.05 | 0 | -0.06 | -55.61 | -1.1 |
| EPS (₹) | 0.00 | -0.00 | -0.01 | -0.00 | 0.00 | -0.00 | -1.01 | -0.02 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Johnson Pharmacare Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 1 | 0 | 1 | 3 | 3 | 0 | 0 | 0 | 0 |
| Operating profit | -0 | -0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | -43 | -43 |
| OPM % | — | — | -1.1% | — | 0.0% | 4.0% | 9% | — | — | — | — |
| Net profit | -0 | -0 | -0 | -0 | 0 | 0 | -1 | -0 | -1 | -56 | -57 |
| EPS (₹) | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 | -0.02 | -0.00 | -0.01 | -1.01 | -1.03 |
TTM is the trailing twelve months to the most recent quarter.
Johnson Pharmacare Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 50 | 50 | 50 | 50 | 50 | 55 | 55 | 55 | 55 | 55 |
| Reserves | 8 | 8 | 8 | 8 | 8 | 3 | 2 | 2 | 1 | -55 |
| Borrowings | 1 | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 21 |
| Other liabilities | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
| Total liabilities | 59 | 60 | 60 | 59 | 59 | 60 | 60 | 60 | 58 | 22 |
| Fixed assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 54 | 54 | 53 | 52 | 52 | 54 | 46 | 46 | 42 | 20 |
| Other assets | 5 | 6 | 7 | 7 | 7 | 6 | 14 | 14 | 16 | 2 |
| Total assets | 59 | 60 | 60 | 59 | 59 | 60 | 60 | 60 | 58 | 22 |
As reported by the company. Total assets equal total liabilities by construction.
Johnson Pharmacare Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 11 | -1 | -1 | 0 | -0 | 5 | -0 | -0 | -2 | -57 |
| Cash from investing | -11 | -0 | 1 | 1 | 0 | -5 | -1 | 0 | 3 | 58 |
| Cash from financing | 0 | 1 | 0 | -1 | 0 | -0 | 1 | 0 | -1 | -0 |
| Net cash flow | 0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -0 |
| Free cash flow | 11 | -1 | -1 | 0 | -0 | 5 | -0 | -0 | -2 | -57 |
| CFO / operating profit | -8,200% | 1,417% | 9,300% | -189% | — | 3,800% | -200% | 25% | 764% | 134% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Johnson Pharmacare Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | -0% | -0% | -0% | -0% | 0% | 0% | 0% | -0% | -0% | -105% |
| Debtor days | — | — | 365 | — | 807 | 118 | 0 | — | — | — |
| Inventory days | — | — | — | — | 0 | 0 | 0 | — | — | — |
| Cash conversion cycle | — | — | 365 | — | 807 | 118 | 0 | — | — | — |
| Working capital days | — | — | 1,932 | — | 2,267 | -9 | -141 | — | — | — |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Johnson Pharmacare Ltd shareholding pattern
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Public | 99.99% | 99.99% | 99.99% | 99.99% | 99.99% | 99.99% | 99.99% | 99.99% |
| No. of shareholders | 1,17,397 | 1,17,101 | 1,17,105 | 1,17,098 | 1,17,101 | 1,17,101 | 1,17,101 | 1,17,101 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Johnson Pharmacare Ltd corporate filings
- Pursuant to PIT (Regulation), 2015 the Trading window shall remain closed from 01st October, 2026 till 48 hours after the declaration of unaudited financial result for the quarter and Half ....Insider Trading / SASTlow impact
- Johnson Pharmacare reports net loss of 1.10 crore for Q1 FY27; financial performance remains weakCompany Updatehigh impact
Cruxal's analysis: Johnson Pharmacare Limited has reported its unaudited financial results for the quarter…
Read the full analysis - Johnson Pharmacare Ltd confirms non-applicability of Regulation 32 for Q1 FY2027Company Updatelow impact
Cruxal's analysis: Johnson Pharmacare Ltd has submitted an undertaking confirming that Regulation 32 of the…
Read the full analysis - Johnson Pharmacare Limited reports nil revenue and net loss of 1.10 lakh for Q1 FY2027Resultlow impact
Cruxal's analysis: Johnson Pharmacare Limited reported nil revenue from operations for the quarter ended…
Read the full analysis - Johnson Pharmacare Limited reports nil revenue and net loss of 1.10 lakh for Q1 FY2027Board Meetinglow impact
Cruxal's analysis: Johnson Pharmacare Limited has released its unaudited financial results for the quarter…
Read the full analysis - Johnson Pharmacare Ltd announces relocation of registered office to AhmedabadCompany Updatelow impact
Cruxal's analysis: Johnson Pharmacare Ltd has received board approval to shift its registered office from…
Read the full analysis - Johnson Pharmacare Limited schedules board meeting for June 2026 quarterly resultsBoard Meetinglow impact
Cruxal's analysis: Johnson Pharmacare Limited has issued a formal intimation regarding a board meeting…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.